Study record

Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition

D'Souza RF, Woodhead JST, Hedges CP et al. · Aging (Albany NY) · 2020

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

In healthy men, circulating MOTS-c was lower with age, while middle-aged and older men had about 1.5-fold higher skeletal muscle MOTS-c expression than young men. Muscle MOTS-c was associated with slow-type muscle markers and, in older men, with muscle quality, and was not associated with ARE-related gene expression.

Limitations

Men only; cross-sectional design; group sizes not reported in the abstract.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedPlasma and skeletal muscle of healthy young, middle-aged and older men
Populationhealthy young (18-30 y), middle-aged (45-55 y) and older (70-81 y) men
DesignCross-sectional age-group comparison
Sample size as reportedNot reported
Control groupyoung men
Route (data field only)Not reported
Endpoints measuredplasma MOTS-c; skeletal muscle MOTS-c expression; myofiber type markers; muscle quality (leg-press load relative to thigh area); ARE-related gene expression
Pathways measuredNRF2 / antioxidant response
Research areasAging · Skeletal muscle
Evidence tierB — Other human study
Publication typesJournal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Not reported
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.